ADAMTS9 and nonpapillary renal cell carcinoma: While ADAMTS9-AS2 overexpression led to significant inhibition of ccRCC cell proliferation, the simultaneous overexpression of miR-27a-3p completely reversed this inhibition (Figure 7B, P < 0.05).